Drug monitoring program supported by AIM
January 28, 2020 - Associated Industries of Missouri (AIM) testified in support of Senate Bill 677 yesterday, sponsored by Sen. Tony Luetkemeyer, that would establish a prescription drug monitoring program in the state. Last week, AIM testified in support of House Bill 1693, similar legislation filed in the House by Rep. Holly Rehder.
"From a business perspective, prescription drug monitoring could help with prescription drug abuse in the workplace," said Ray McCarty, president and CEO of Associated Industries of Missouri. "Helping stop the abuse of prescription drugs may help reduce workplace injuries, reduce employee absenteeism, and increase the overall health of the workforce."
SB 677 was heard yesterday and no action was taken on the bill, although a vote may be expected soon. A committee vote is expected on HB 1693 tomorrow in the House Insurance Policy Committee.